Literature DB >> 19679555

Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43.

Gabriel J Villares1, Andrey S Dobroff, Hua Wang, Maya Zigler, Vladislava O Melnikova, Li Huang, Menashe Bar-Eli.   

Abstract

Protease-activated receptor-1 (PAR-1) is a key player in melanoma metastasis with higher expression seen in metastatic melanoma cell lines and tissue specimens. cDNA microarray and Western blot analyses reveal that the gap junctional intracellular communication molecule connexin 43 (Cx-43), known to be involved in tumor cell diapedesis and attachment to endothelial cells, is significantly decreased after PAR-1 silencing in metastatic melanoma cell lines. Furthermore, Cx-43 promoter activity was significantly inhibited in PAR-1-silenced cells, suggesting that PAR-1 regulates Cx-43 at the transcriptional level. Chromatin immunoprecipitation studies showed a reduction in the binding of SP-1 and AP-1 transcription factors to the promoter of Cx-43. Both transcription factors have been shown previously to be required for maximal Cx-43 promoter activity. These results were corroborated by mutating the AP-1 and SP-1 binding sites resulting in decreased Cx-43 promoter activity in PAR-1-positive cells. Moreover, as Cx-43 has been shown to facilitate arrest of circulating tumor cells at the vascular endothelium, melanoma cell attachment to endothelial cells was significantly decreased in PAR-1-silenced cells, with this effect being abrogated after PAR-1 rescue. Herein, we report that up-regulation of PAR-1 expression, seen in melanoma progression, mediates high levels of Cx-43 expression. As both SP-1 and AP-1 transcription factors act as positive regulators of Cx-43, our data provide a novel mechanism for the regulation of Cx-43 expression by PAR-1. Indeed, Cx-43 expression was restored following PAR-1 rescue in PAR-1-silenced cells. Taken together, our data support the tumor promoting function of Cx-43 in melanoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679555      PMCID: PMC2727665          DOI: 10.1158/0008-5472.CAN-09-0300

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Localization of regulatory protein binding sites in the proximal region of human myometrial connexin 43 gene.

Authors:  C O Echetebu; M Ali; M G Izban; L MacKay; R E Garfield
Journal:  Mol Hum Reprod       Date:  1999-08       Impact factor: 4.025

2.  The cloned thrombin receptor is necessary and sufficient for activation of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts. Loss of responses in fibroblasts from receptor knockout mice.

Authors:  J Trejo; A J Connolly; S R Coughlin
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

3.  PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.

Authors:  Adrienne Boire; Lidija Covic; Anika Agarwal; Suzanne Jacques; Sheida Sherifi; Athan Kuliopulos
Journal:  Cell       Date:  2005-02-11       Impact factor: 41.582

Review 4.  The role of altered cell-cell communication in melanoma progression.

Authors:  Nikolas K Haass; Keiran S M Smalley; Meenhard Herlyn
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

5.  Thrombin receptor overexpression in malignant and physiological invasion processes.

Authors:  S Even-Ram; B Uziely; P Cohen; S Grisaru-Granovsky; M Maoz; Y Ginzburg; R Reich; I Vlodavsky; R Bar-Shavit
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

6.  Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells.

Authors:  Kristina K Hansen; Mahmoud Saifeddine; Morley D Hollenberg
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

7.  Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.

Authors:  S Huang; D Jean; M Luca; M A Tainsky; M Bar-Eli
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

8.  Functional analysis of the connexin43 gene promoter in vivo and in vitro.

Authors:  J R De Leon; P M Buttrick; G I Fishman
Journal:  J Mol Cell Cardiol       Date:  1994-03       Impact factor: 5.000

9.  Cytoplasmic dye transfer between metastatic tumor cells and vascular endothelium.

Authors:  M E el-Sabban; B U Pauli
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

View more
  26 in total

1.  Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.

Authors:  Gabriel J Villares; Maya Zigler; Andrey S Dobroff; Hua Wang; Renduo Song; Vladislava O Melnikova; Li Huang; Russell R Braeuer; Menashe Bar-Eli
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 2.  PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis.

Authors:  Maya Zigler; Takafumi Kamiya; Emily C Brantley; Gabriel J Villares; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2011-10-18       Impact factor: 12.701

Review 3.  An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs.

Authors:  Jing Wang; Yifan Zhang; Ning Zhang; Chuandong Wang; Tanja Herrler; Qingfeng Li
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

4.  Expression of connexin 43 and E-cadherin in choroidal melanoma.

Authors:  Ying-Ying Mou; Gui-Qiu Zhao; Jin-Yong Lin; Jie Zhao; Hong Lin; Li-Ting Hu; Qiang Xu; Qing Wang; Wei-Rong Sun
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

Review 5.  Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.

Authors:  Russell R Braeuer; Maya Zigler; Gabriel J Villares; Andrey S Dobroff; Menashe Bar-Eli
Journal:  Semin Cancer Biol       Date:  2010-12-13       Impact factor: 15.707

6.  MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.

Authors:  Hanaa Aissaoui; Célia Prévost; Ahmed Boucharaba; Kamel Sanhadji; Jean-Claude Bordet; Claude Négrier; Habib Boukerche
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.157

7.  Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype.

Authors:  Antonietta Silini; Carmen Ghilardi; Camilla Ardinghi; Sergio Bernasconi; Paolo Oliva; Fabio Carraro; Antonella Naldini; Maria Rosa Bani; Raffaella Giavazzi
Journal:  Clin Exp Metastasis       Date:  2009-12-20       Impact factor: 5.150

8.  CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.

Authors:  Vladislava O Melnikova; Andrey S Dobroff; Maya Zigler; Gabriel J Villares; Russell R Braeuer; Hua Wang; Li Huang; Menashe Bar-Eli
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

9.  From melanocyte to metastatic malignant melanoma.

Authors:  Bizhan Bandarchi; Linglei Ma; Roya Navab; Arun Seth; Golnar Rasty
Journal:  Dermatol Res Pract       Date:  2010-08-11

10.  Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.

Authors:  Vladislava O Melnikova; Krishnakumar Balasubramanian; Gabriel J Villares; Andrey S Dobroff; Maya Zigler; Hua Wang; Frederik Petersson; Janet E Price; Alan Schroit; Victor G Prieto; Mien-Chie Hung; Menashe Bar-Eli
Journal:  J Biol Chem       Date:  2009-08-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.